AACR Annual Meeting 2027
Orlando, FL
April 2, 2027 – April 7, 2027

SciLeads will be exhibiting at the AACR Annual Meeting 2027, bringing together the global cancer research community at the Orange County Convention Center in Orlando, Florida.
Come see us at our booth! We’re number 2476.
Hosted by the American Association for Cancer Research (AACR), the meeting connects scientists, clinicians, industry professionals, and patient advocates to share advances in cancer science and medicine. From fundamental cancer biology to new therapeutic approaches, the event offers opportunities to explore research and connect with the people translating discoveries into better treatments.
We look forward to meeting attendees and sharing how SciLeads helps life science sales and marketing teams identify relevant researchers, understand their scientific interests, and personalize outreach.
About AACR 2027
The AACR Annual Meeting spans the breadth of cancer research, including prevention, early detection, cancer biology, translational research, clinical studies, and survivorship.
The 2027 theme, “Delivering Discovery Science: The Bridge to Breakthrough Therapeutics,” highlights the connection between scientific discovery and advances in cancer treatment. The program includes plenary presentations, symposia, educational sessions, methods workshops, and discussions of emerging therapies and technologies.
Key Details for AACR 2027
- Location: Orange County Convention Center, Orlando, Florida, USA
- Dates: April 2–7, 2027
- Program: View the official AACR Annual Meeting 2027 Program
Quick Links for AACR 2027
- AACR Annual Meeting 2027 Main Event Page
- Registration Information
- Exhibitor Information
- Key Dates and Deadlines
Deadlines for AACR 2027
- December 7, 2026: Early registration deadline for the lowest rates.
- January 6, 2027: Late-breaking and clinical trials abstract submission deadline.
- November 10, 2026: Regular/First Abstract Submission Deadline
- April 2, 2027: Meeting begins.
Key Topics and Speakers for AACR 2027
- Discovery Science and New Therapeutics: The opening plenary explores how scientific discoveries translate into breakthrough treatments, featuring Stephen Quake, Caroline Chung, Alessio Ciulli, and Elizabeth M. Jaffee.
- Neuroscience and Cancer: Michelle L. Monje, Shawn Hervey-Jumper, Susan M. Kaech, and Erica Sloan examine how neural circuits influence tumor progression, immunity, and therapy.
- Cancer Adaptation and Resistance: Sessions investigate how tumors develop, evade immune responses, and persist, with plenary speakers including Gabriel A. Rabinovich, Kornelia Polyak, Lieping Chen, and Vera Gorbunova.
- Emerging Cancer Treatments: Topics include antibody-drug conjugates, radioligand therapies, RNA therapeutics, cancer vaccines, and next-generation cell therapies.
- AI and Precision Oncology: Sessions explore AI-driven discovery, digital pathology, advanced diagnostics, and approaches to personalized cancer treatment.
- Prevention, Early Detection, and Population Health: Discussions address cancer risk, earlier diagnosis, health disparities, and the effects of stress on cancer biology and population health.
Who Attends AACR 2027
- Cancer researchers and principal investigators
- Clinical researchers, oncologists, and health care professionals
- Biotechnology and pharmaceutical industry professionals
- Graduate students, postdoctoral fellows, and early-career investigators
- Scientific technology and service providers
- Patient advocates and cancer survivors
- Science and health policy professionals
“SciLeads has been critical to the success of our sales and marketing efforts. I don't know where we would be without its data and insights.”